As on Mar 2024Our R&D Excellence in Numbers
1995
Year of Recognition, by DSIR, Ministry of Science & Technology, GOI
50+
Highly qualified scientists driving research and innovation
25+
Products in the development pipeline
4+
Regulated markets: Europe, UK, Canada, Australia
10+
Therapeutic areas: Anti-diabetic, Cardiovascular, CNS, Antibiotics, etc.
3+
Key dosage forms: Tablets, Capsules, Granules (Immediate, Extended, Delayed release)